I agree that this site is using cookies. You can find further informations here.
X
Govaerts, Anne-Sophie
51  results:
Search for persons X
?
1

COLUMBUS-AD: Phase III Study of Adjuvant Encorafenib + Bini..:

van Akkooi, Alexander CJ ; Hauschild, Axel ; Long, Georgina V...
Future Oncology.  19 (2023)  30 - p. 2017-2027 , 2023
Link: https://doi.org/10.2217/..
 
?
2

A phase II study of monalizumab in patients with recurrent/..:

Galot, Rachel ; Le Tourneau, Christophe ; Saada-Bouzid, Esma...
European Journal of Cancer.  158 (2021)  - p. 17-26 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Organ Preservation and Late Functional Outcome in Oropharyn..:

Stelmes, Jean-Jacques ; Gregoire, Vincent ; Poorten, Vincent Vander...
Frontiers in Oncology.  9 (2019)  - p. , 2019
Link: https://doi.org/10.3389/..
 
?
4

Pharmacologically directed strategies in academic anticance..:

on behalf of the EORTC-PAMM Group ; Hendriks, Hans R ; Govaerts, Anne-Sophie...
British Journal of Cancer.  117 (2017)  2 - p. 195-202 , 2017
Link: https://doi.org/10.1038/..
 
?
5

Erratum to: Phase I study of lonafarnib (SCH66336) in combi..:

Milojkovic Kerklaan, Bojana ; Diéras, Veronique ; Le Tourneau, Christophe...
Cancer Chemotherapy and Pharmacology.  71 (2013)  2 - p. 553-553 , 2013
Link: https://doi.org/10.1007/..
 
?
6

Phase I study of lonafarnib (SCH66336) in combination with ..:

Kerklaan, Bojana Milojkovic ; Diéras, Veronique ; Le Tourneau, Christophe...
Cancer Chemotherapy and Pharmacology.  71 (2012)  1 - p. 53-62 , 2012
Link: https://doi.org/10.1007/..
 
?
7

Retrovirus-Mediated Gene Transfer of the Human Multidrug Re..:

Machiels, Jean-Pascal ; Govaerts, Anne-Sophie ; Guillaume, Thierry...
Human Gene Therapy.  10 (1999)  5 - p. 801-811 , 1999
Link: https://doi.org/10.1089/..
 
?
8

Tumor Microenvironment Modifications Induced by Afatinib in..:

Beyaert, Simon P ; Loriot, Axelle E ; Huyghe, Nicolas D...
boreal:279359.  , 2023
Link: http://hdl.handle.net/20..
 
?
9

Tumor Microenvironment Modifications Induced by Afatinib in..:

Beyaert, Simon P ; Loriot, Axelle E ; Huyghe, Nicolas D...
boreal:279359.  , 2023
Link: http://hdl.handle.net/20..
 
?
10

A phase II study of monalizumab in patients with recurrent/..:

Galot, Rachel ; Le Tourneau, Christophe ; Saada-Bouzid, Esma...
boreal:252117.  , 2021
Link: http://hdl.handle.net/20..
 
?
11

A phase II study of monalizumab in patients with recurrent/..:

Galot, Rachel ; Le Tourneau, Christophe ; Saada-Bouzid, Esma...
boreal:252117.  , 2021
Link: http://hdl.handle.net/20..
 
?
12

Organ Preservation and Late Functional Outcome in Oropharyn..:

Stelmes, Jean-Jacques ; Gregoire, Vincent ; Poorten, Vincent Vander...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817682/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Organ Preservation and Late Functional Outcome in Oropharyn..:

Stelmes, Jean-Jacques ; Gregoire, Vincent ; Poorten, Vincent Vander...
https://boris.unibe.ch/137964/.  , 2019
Link: https://boris.unibe.ch/1..
 
?
14

The role of pharmacology in anticancer drug development:

Peters, Godefridus ; Govaerts, Anne-Sophie ; Hendriks, Hans.
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.5599/admet.6.1.496.  , 2018
Link: https://hrcak.srce.hr/19..
 
?
15

Personalized biomarker-based treatment strategy for patient..:

Galot, Rachel ; Le Tourneau, Christophe ; Guigay, Joël...
boreal:212726.  , 2018
Link: http://hdl.handle.net/20..
 
1-15